Dec 19, 2024, 01:17 by User Not Found

Clinical Research News | In this year’s last episode of the Scope of Things, host Deborah Borfitz discusses concerns surrounding obesity studies and treatments, debate over the European Union AI Act, the first international-level clinical study using secure multiparty computation, the NIH’s ChatGPT tool that matches potential volunteers to relevant studies, and more.

Dec 18, 2024, 08:38 by

Oxford Nanopore Technologies will participate in a groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness.

Dec 18, 2024, 08:37 by

Integration between eClinical’s elluminate Clinical Data Cloud and Snowflake offers modern data architecture to power clinical data science and AI, unlock data value for healthcare outcomes

Dec 18, 2024, 01:00 by User Not Found

Clinical Research News | European researchers have achieved a breakthrough in privacy-preserving clinical studies through the first international application of secure multiparty computation (MPC). This advanced cryptographic method enabled institutions across borders to collaborate without sharing sensitive patient data, paving the way for privacy-respecting global research.

Dec 17, 2024, 08:16 by

BetaGlueBetaGlue announced today that the ENEA-Tech and Biomedical Foundation has invested €6m bringing the total raised in the current funding round to €24m.

Dec 17, 2024, 01:00 by User Not Found

Clinical Research News | The U.S. Food and Drug Administration (FDA) expects sponsors of certain clinical studies to submit a Diversity Action Plan outlining enrollment goals, their rationale, and means of achieving those intentions, as the agency spells out in some detail in its much anticipated draft guidance issued in June. At the same time, pushback against diversity, equity, and inclusion (DEI) initiatives has been ramping up in industry hallways across the land to the point where merely uttering the term “DEI” can evoke sneers.

Dec 13, 2024, 07:57 by

Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.

Dec 13, 2024, 07:57 by

VieCure announced that Commonwealth Cancer Center will deploy its Halo Intelligence platform - the first AI-enabled community oncology care solution. Clinicians will use the platform to manage precision oncology data and help determine the optimal personalized treatment path for patients across rural Kentucky.

Dec 13, 2024, 01:00 by User Not Found

Clinical Research News | In the past year, the rise of generative AI has created much buzz within the life sciences industry. This technology promises to shorten the lengthy timelines typically seen when bringing new therapies to market, providing a glimmer of hope (perhaps hype?) for an industry known for its methodical pace. The challenge is to harness AI’s capabilities safely, securely, and effectively to accelerate every phase of the drug discovery and development lifecycle.

Dec 11, 2024, 08:07 by

Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.

Dec 11, 2024, 08:07 by

Dec 10, 2024, 05:38 by

Ceryx today announced that the first patient has been enrolled in the RSA-Pace multi-center study at Waikato Hospital in Hamilton, New Zealand.

Dec 10, 2024, 05:38 by

Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.

Dec 10, 2024, 01:00 by User Not Found

Clinical Research News | Can you have too much of a good thing? Or perhaps, can you gather too much of a good thing? When it comes to clinical trials, it looks like the answer is yes. The industry has seen an exponential increase in the volume of data collected in clinical trials. When one considers all the talk of AI and what might be possible with more and more quality data, this growth in data gathering seems to make sense.

Dec 6, 2024, 01:00 by User Not Found

Clinical Research News | While randomized clinical trials (RCTs) have rightly long been considered the gold standard for establishing the safety and efficacy of new medications, their strict inclusion and exclusion criteria narrow participant types. For example, RCTs tend to exclude certain patient sub-groups, especially those with specific comorbidities. The scientific rationale behind these practices results from a desire to assess the benefit/risk ratio in a stepwise fashion, starting with the most homogenous population to more heterogeneous ones as development of a therapeutic progresses.

Dec 4, 2024, 08:30 by

Abselion has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.

Dec 4, 2024, 01:00 by User Not Found

Clinical Research News | The PAN Foundation, a nonprofit that has been providing financial assistance to patients with life-threatening, chronic, and rare diseases since 2004, has just launched an Opening Doors to Clinical Trials initiative aiming to improve equitable access to studies. Assistance is now freely available to people everywhere in the form of basic education about trials, a user-friendly trial finder tool, and a live person who can answer questions and direct them to needed resources.

Dec 3, 2024, 07:41 by

Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.

Dec 3, 2024, 01:00 by User Not Found

Clinical Research News | At the SCOPE Europe conference held in Barcelona last month, clinical trials leaders highlighted transformative shifts toward diversity, inclusion, and patient engagement in study designs. Liz Bristow, director of patient recruitment and retention at AstraZeneca, and Jodie Allen, global senior director of clinical trial diversity at AstraZeneca UK, outlined key advancements and persistent challenges in achieving equitable patient representation across clinical trials.

Dec 2, 2024, 08:29 by

2BScientific Limited proudly announces the opening of its first European hub in Munich, Germany, establishing a strong base to service the growing European markets. The hub will also enable the company to enter new supplier partnerships, enhancing the range of products available to its European customers and broadening the reach of its existing suppliers.